بدائل البحث:
larvae increases » large increases (توسيع البحث), larger increases (توسيع البحث), care increased (توسيع البحث)
values decrease » values increased (توسيع البحث), largest decrease (توسيع البحث)
cr values » cor values (توسيع البحث), ct values (توسيع البحث), c values (توسيع البحث)
i larvae » _ larval (توسيع البحث)
b large » _ large (توسيع البحث), i large (توسيع البحث), _ larger (توسيع البحث)
a large » _ large (توسيع البحث)
larvae increases » large increases (توسيع البحث), larger increases (توسيع البحث), care increased (توسيع البحث)
values decrease » values increased (توسيع البحث), largest decrease (توسيع البحث)
cr values » cor values (توسيع البحث), ct values (توسيع البحث), c values (توسيع البحث)
i larvae » _ larval (توسيع البحث)
b large » _ large (توسيع البحث), i large (توسيع البحث), _ larger (توسيع البحث)
a large » _ large (توسيع البحث)
-
101
Image_8_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF
منشور في 2021"…Cachexia-inducing factors (CIFs) have been reported in colorectal cancer and pancreatic adenocarcinoma, but their value in diffuse large B-cell lymphoma (DLBCL) requires further genetic research.…"
-
102
Image_4_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF
منشور في 2021"…Cachexia-inducing factors (CIFs) have been reported in colorectal cancer and pancreatic adenocarcinoma, but their value in diffuse large B-cell lymphoma (DLBCL) requires further genetic research.…"
-
103
Image_6_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF
منشور في 2021"…Cachexia-inducing factors (CIFs) have been reported in colorectal cancer and pancreatic adenocarcinoma, but their value in diffuse large B-cell lymphoma (DLBCL) requires further genetic research.…"
-
104
DataSheet_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx
منشور في 2021"…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …"
-
105
-
106
Table 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx
منشور في 2025"…However, the specific role and underlying molecular mechanisms of cholesterol metabolism alterations in diffuse large B-cell lymphoma (DLBCL) remain poorly understood.…"
-
107
-
108
Data_Sheet_1_The Proximal Drivers of Large Fires: A Pyrogeographic Study.docx
منشور في 2020"…As in most fire-prone environments, the majority of annual burned area is due to a relatively small number of large fires. We train and test an Artificial Neural Network’s ability to predict spatial patterns in the probability of large fires (>1,250 ha) in forests and grasslands as a function of proxies of the four major controls on fire activity. …"
-
109
Data Sheet 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx
منشور في 2025"…However, the specific role and underlying molecular mechanisms of cholesterol metabolism alterations in diffuse large B-cell lymphoma (DLBCL) remain poorly understood.…"
-
110
-
111
-
112
-
113
DataSheet1_Adverse childhood experiences, brain function, and psychiatric diagnoses in a large adult clinical cohort.pdf
منشور في 2024"…However, no study has explored these associations in a large clinical population to identify brain regions that may mediate the relationship between ACEs and psychiatric diagnoses. …"
-
114
-
115
-
116
T. <i>spiralis</i> infection increases Th2 cells population in the lung tissues.
منشور في 2022الموضوعات: -
117
-
118
Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx
منشور في 2025"…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …"
-
119
-
120